CIRCADIAN VARIATION IN PLASMA HOMOVANILLIC-ACID LEVEL DURING AND AFTER ALCOHOL-WITHDRAWAL IN ALCOHOLIC PATIENTS

被引:18
|
作者
SANO, H [1 ]
SUZUKI, Y [1 ]
OHARA, K [1 ]
YAZAKI, R [1 ]
ISHIGAKI, T [1 ]
YOKOYAMA, T [1 ]
OHARA, K [1 ]
机构
[1] SEIMEI HOSP, FUJI 417, JAPAN
关键词
CIRCADIAN VARIATION; HOMOVANILLIC ACID (HVA); ALCOHOLISM; ALCOHOL WITHDRAWAL SYNDROME; DELIRIUM-TREMENS (DT);
D O I
10.1111/j.1530-0277.1992.tb00697.x
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Alcohol withdrawal symptoms in alcoholics were objectively evaluated and classified into three groups according to the severity of their symptoms, and circadian variation in their plasma homovanillic acid (HVA) concentrations was determined at three different intervals after cessation of drinking. The subjects studied were 19 male alcoholic patients and five age-matched healthy male volunteers. Circadian variation in plasma HVA was compared between each patient group and the control group by two-way ANOVA. In the sympathetic overactivity (SO) group comprising nine patients and in the clouding of sensorium (CS) group comprising five patients, plasma HVA concentrations on the 2nd and 3rd day and on the 6th and 7th day after cessation of drinking were low but recovered almost normal levels on the 21st and 22nd postcessation day. The delirium tremens group (DT) comprising five patients, however, showed significantly higher plasma HVA than the control group except on the 6th and 7th postcessation day. The higher plasma HVA in the DT group indicates that there is some sort of preparatory state whereby dopamine metabolism is involved in the appearance of hallucinations at alcohol withdrawal and can possibly be used as a predictor of otherwise hardly predictable delirium tremens.
引用
收藏
页码:1047 / 1051
页数:5
相关论文
共 50 条
  • [1] CIRCADIAN VARIATION IN PLASMA 5-HYDROXYINDOLEACETIC ACID LEVEL DURING AND AFTER ALCOHOL-WITHDRAWAL - PHASE ADVANCES IN ALCOHOLIC PATIENTS COMPARED WITH NORMAL SUBJECTS
    SANO, H
    SUZUKI, Y
    YAZAKI, R
    TAMEFUSA, K
    OHARA, K
    YOKOYAMA, T
    MIYASATO, K
    OHARA, K
    ACTA PSYCHIATRICA SCANDINAVICA, 1993, 87 (04) : 291 - 296
  • [2] CIRCADIAN VARIATIONS IN PLASMA MONOAMINE METABOLITES LEVEL IN ALCOHOLIC PATIENTS - A POSSIBLE PREDICTOR OF ALCOHOL-WITHDRAWAL DELIRIUM
    SANO, H
    SUZUKI, Y
    OHARA, K
    MIYASATO, K
    YOKOYAMA, T
    OHARA, K
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 1994, 18 (04): : 741 - 752
  • [3] CIRCADIAN VARIATION OF PLASMA HOMOVANILLIC-ACID LEVELS IS ATTENUATED BY FLUPHENAZINE IN PATIENTS WITH SCHIZOPHRENIA
    DORAN, AR
    LABARCA, R
    WOLKOWITZ, OM
    ROY, A
    DOUILLET, P
    PICKAR, D
    ARCHIVES OF GENERAL PSYCHIATRY, 1990, 47 (06) : 558 - 563
  • [4] PLASMA HOMOVANILLIC-ACID AND TARDIVE-DYSKINESIA DURING NEUROLEPTIC MAINTENANCE AND WITHDRAWAL
    KIRCH, D
    HATTOX, S
    BELL, J
    MURPHY, R
    FREEDMAN, R
    PSYCHIATRY RESEARCH, 1983, 9 (03) : 217 - 223
  • [5] CIRCADIAN-RHYTHM IN HORMONE-RELEASING DURING ALCOHOL-WITHDRAWAL AND AFTER WITHDRAWAL
    TSUCHIYAMA, Y
    UCHIMURA, N
    NAKAZAWA, Y
    OHSHIMA, H
    OHSHIMA, M
    NEUROSCIENCES-JAPAN, 1995, 21 : P167 - P170
  • [6] QUANTIFICATION OF THE ALCOHOL-WITHDRAWAL SYNDROME IN 487 ALCOHOLIC PATIENTS
    BENZER, DG
    JOURNAL OF SUBSTANCE ABUSE TREATMENT, 1990, 7 (02) : 117 - 123
  • [7] LOW PLASMA HOMOVANILLIC-ACID LEVELS IN RECENTLY ABSTINENT ALCOHOLIC MEN
    FULTON, MK
    KRAMER, G
    MOELLER, FG
    CHAE, YL
    ISBELL, PG
    PETTY, F
    AMERICAN JOURNAL OF PSYCHIATRY, 1995, 152 (12): : 1819 - 1820
  • [8] CHANGES IN PLASMA HOMOVANILLIC-ACID DURING THE TRH-TEST
    MARKIANOS, M
    HATZIMANOLIS, J
    NEUROENDOCRINOLOGY LETTERS, 1986, 8 (04) : 199 - 203
  • [9] FREE AND CONJUGATED PLASMA HOMOVANILLIC-ACID IN SCHIZOPHRENIC-PATIENTS
    GARCIA, A
    GALINOWSKI, A
    GUICHENEY, P
    MIGNOT, E
    LOO, H
    MEYER, P
    BIOLOGICAL PSYCHIATRY, 1989, 26 (01) : 87 - 96
  • [10] FREE AND CONJUGATED PLASMA HOMOVANILLIC-ACID IN SCHIZOPHRENIC-PATIENTS
    GARCIA, A
    GALINOWSKI, A
    MIGNOT, E
    GUICHENEY, P
    LOO, H
    MEYER, P
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 1988, 2 (02) : 123 - 124